82019-32-7 Usage
General Description
7-Bromo-1-methyl-1H-quinoxalin-2-one is a chemical compound with the molecular formula C10H7BrN2O. It is a quinoxaline derivative, which is a class of nitrogen-containing heterocyclic compounds. This chemical has potential applications in the pharmaceutical industry, particularly in the development of new drugs. It may also have other industrial uses, such as in the production of specialty chemicals or as a research reagent. Its precise properties and potential uses would depend on further research and testing.
Check Digit Verification of cas no
The CAS Registry Mumber 82019-32-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,0,1 and 9 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 82019-32:
(7*8)+(6*2)+(5*0)+(4*1)+(3*9)+(2*3)+(1*2)=107
107 % 10 = 7
So 82019-32-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H7BrN2O/c1-12-8-4-6(10)2-3-7(8)11-5-9(12)13/h2-5H,1H3
82019-32-7Relevant articles and documents
Metal-Free Direct Oxidative C?N Bond Coupling of Quinoxalin-2(1H)-ones with Azoles under Mild Conditions
Cai, Yuepiao,Du, Xinyue,Guo, Jingwen,Xia, Qinqin,Zhang, Lina,Zhang, Liting
supporting information, p. 2230 - 2238 (2021/07/22)
Direct C3?H amination of quinoxalin-2(1H)-ones with azoles under mild conditions promoted by PIFA has been achieved in good yield in a very fast manner. Mechanistic study revealed that the reaction proceeds through a radical process. In addition, this method could be applied to gram-scale reaction.
HETEROCYCLIC SULFONAMIDES AS RAF INHIBITORS
-
, (2012/09/21)
Compounds of Formula (I) are useful for inhibition of Raf kinases. Methods of using compounds of Formula (I), stereoisomers, tautomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
